Kader Thiam

Company: genOway

Job title: SVP Preclinical Models

Seminars:

Precise and translational preclinical models for assessment of immune-targeting agents 2:30 pm

Outlining BRGSF-HIS mice: immunodeficient mice displaying functional human lymphoid and myeloid compartments, without side effects Assessing efficacy and toxicity induced by immune checkpoint inhibitors, cell engagers and combo therapies in BRGSF-HIS mice, which displays a wide therapeutic window Showcase of assessment of immune targeting agents in syngeneic humanized modelsRead more

day: Day Two